Deallus latest news

The latest news from Deallus pharmaceutical and life science industry experts

HIV/AIDS

2022-12-01T11:26:10+00:00News, White Paper|

Human immunodeficiency virus (HIV) is the virus that is responsible for Acquired Immune Deficiency Syndrome (AIDS). HIV continues to be a major global public health issue having claimed the lives of 36.3 million people so far, according to World Health Organization (WHO).

BIO 2022: Biotechnology Innovation Organization (BIO) Convention

2022-06-09T18:44:32+01:00News|

We’re excited to be attending The BIO International Convention. Jack Florio, Partner in Strategy Consulting at Deallus will be joining more than 3,000 delegates and exploring the latest innovation within the biotech space, as well as making the most of opportunities to meet and network with global thought leaders and industry peers.

ASCO 2022 Summary of findings in oncology and China market

2022-05-25T16:46:02+01:00News|

China is never a new word in ASCO. China-originated innovation made its ASCO debut in 2011, and since then we have been seeing more Chinese pharma bringing exciting clinical progress in the oncology space. This year, there will be 19 oral presentations and more than 70 posters from Chinese pharma, with the keyword 'China’ hit a record high of nearly 350 times in the ASCO Agenda.

Go to Top